CEMPE PN Stock Quote MAPT4 - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

6.45

Bid

0.00

Ask

0.00

Volume

0.00 Day's Range 0.00

4.08 52 Week Range 49.00

Market Cap

2.996M

Previous Close

6.45

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,107

Shares Outstanding

464,440

Dividend Yield

PE Ratio

-13.07

Earnings Per Share (EPS)

-0.33

Revenue

Net Profit

-151k

Sector

Offices-holdng Companies,nec

Industry

Offices-holdng Companies,nec

Website

www.cemepe.com.br

Headquarters

Rio De Janeiro, Rio De Janeiro, Bra

Founded

1970

Cemepe Invests Sa is listed in the Offices-holdng Companies sector of the Brazil Bovespa Exchange with ticker MAPT4. The last closing price for CEMPE PN was R$6.45. Over the last year, CEMPE PN shares have traded in a share price range of R$ 4.08 to R$ 49.00.

CEMPE PN currently has 464,440 shares outstanding. The market capitalization of CEMPE PN is R$3 million. CEMPE PN has a price to earnings ratio (PE ratio) of -13.07.

FeaturedPOET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

TransCode Therapeutics, Inc. Announces Closing of Public Offering

BOSTON, July 24, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed to more effectively treating...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

TransCode Therapeutics, Inc. Announces Pricing of Public Offering

BOSTON, July 22, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed to more effectively...

Form 424B5 - Prospectus [Rule 424(b)(5)]

TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

BOSTON, July 22, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed to more effectively treating...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	6.45	6.45	6.45	100	6.45	PR
4	0.95	17.2727272727	5.5	6.7	5.5	1067	6.12125	PR
12	0.45	7.5	6	6.7	4.82	1107	5.86825301	PR
26	-3.53	-35.370741483	9.98	13.01	4.08	3141	7.27201498	PR
52	-1.49	-18.765743073	7.94	49	4.08	2823	8.36531083	PR
156	-31.05	-82.8	37.5	49	4.08	2378	8.66845828	PR
260	3.96	159.036144578	2.49	249.01	2.49	2492	29.61268565	PR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PSVM11PORTO SUDESTE VM SA	R$ 6.92 (43.27%)	100
AMER3Americanas SA	R$ 0.63 (14.55%)	59.92k
MRSA3BMrs Logistica Sa	R$ 29.99 (11.07%)	200
DTCY3Dtcom Direct To Company Sa ex Dtc Direct To Company SA	R$ 6.86 (9.06%)	1.8k
ESTR4Manufatura Brinquedos Estrela Sa	R$ 2.16 (7.46%)	10.7k
FRIO3Metalfrio Solutions Sa	R$ 220.00 (-12.00%)	7.3k
MWET4Wetzel Sa (ex Metalurgica Wetzel Sa)	R$ 8.32 (-10.92%)	400
MNPR3Minupar Participacoes Sa	R$ 13.51 (-9.15%)	2k
BIOM3Biomm SA	R$ 9.47 (-8.94%)	964
TCSA3Tecnisa Sa	R$ 2.06 (-8.44%)	34.96k
SMFT3Smartfit Escola DE Ginastica E Danca S.A.	R$ 20.67 (-2.41%)	4.25M
GGPS3GPS Participacoes e Empreendimentos S.A.	R$ 17.73 (0.91%)	2.91M
TEND3Construtora Tenda Sa	R$ 13.02 (0.00%)	2.53M
MDNE3Moura Dubeux Engenharia SA	R$ 14.16 (0.07%)	614.9k
TUPY3Tupy Sa	R$ 24.84 (0.57%)	517.5k